VERONICA TORRES CERVANTES: Open Payments
NPI 1942917562 · ANTHONY, NM. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$747 in 26 payments from 8 companies in 2025. Trend: 2023 $16 · 2024 $337 · 2025 $747
Food & beverage: $747
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $160 |
| Vifor Pharma, Inc. | 1 | $125 |
| Travere Therapeutics, Inc. | 7 | $116 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $105 |
| Ardelyx, Inc. | 3 | $78 |
| Novo Nordisk Inc | 3 | $69 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $63 |
| SCPHARMACEUTICALS INC. | 2 | $31 |
Products named: Veltassa, LOKELMA, Kerendia, IBSRELA, JARDIANCE, FARXIGA, Ozempic, FUROSCIX.
Industry payments across NM — which companies pay providers there.
